Form 8.3

Summary by AI BETAClose X

Qube Research & Technologies disclosed on 11-11-2026 an economic position in Bodycote plc via 5,551,808 cash-settled derivatives representing 3.26% of the 17 3/11p ordinary shares, with 0 direct shares owned (0.00%) and 0 short positions; the exposure arises from equity swaps executed at approximately 917.00–918.50 pence per share and is cash-settled (no voting rights), and the filer reported no stock-settled derivatives, subscription rights, indemnities or other arrangements that would alter voting or ownership control.

Disclaimer*

Companies

Bodycote (BOY)
UK 100

Latest directors dealings